CVS Health Corporation
CVS
$66.97
-$0.88-1.30%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.75% | 3.93% | 5.96% | 7.03% | 9.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.75% | 3.93% | 5.96% | 7.03% | 9.02% |
| Cost of Revenue | 5.99% | 5.95% | 7.89% | 8.73% | 11.17% |
| Gross Profit | -2.54% | -7.56% | -4.69% | -2.06% | -2.12% |
| SG&A Expenses | 4.53% | 4.94% | 5.74% | 4.30% | 4.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.82% | 5.84% | 7.64% | 8.20% | 10.34% |
| Operating Income | -24.92% | -42.35% | -32.83% | -19.09% | -18.16% |
| Income Before Tax | -27.23% | -44.97% | -42.10% | 132.03% | 72.80% |
| Income Tax Expenses | -23.10% | -44.31% | -42.09% | 109.01% | 57.75% |
| Earnings from Continuing Operations | -28.65% | -45.20% | -42.10% | 141.02% | 78.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 224.14% | 216.67% | 128.57% | 41.67% | -38.10% |
| Net Income | -27.88% | -44.70% | -41.89% | 142.50% | 78.87% |
| EBIT | -24.92% | -42.35% | -32.83% | -19.09% | -18.16% |
| EBITDA | -17.70% | -31.08% | -23.65% | -12.91% | -12.60% |
| EPS Basic | -26.54% | -43.51% | -40.91% | 141.13% | 80.52% |
| Normalized Basic EPS | -19.66% | -40.08% | -33.72% | -20.57% | -20.00% |
| EPS Diluted | -26.40% | -43.35% | -40.69% | 143.19% | 82.40% |
| Normalized Diluted EPS | -19.53% | -39.99% | -33.62% | -20.51% | -19.89% |
| Average Basic Shares Outstanding | -1.62% | -2.08% | -1.94% | -1.93% | -1.97% |
| Average Diluted Shares Outstanding | -1.83% | -2.23% | -2.10% | -1.98% | -2.08% |
| Dividend Per Share | 7.26% | 9.92% | 9.94% | 9.96% | 9.98% |
| Payout Ratio | 0.46% | 0.95% | 0.86% | -0.56% | -0.40% |